日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

TP53 variant clusters stratify phenotypic diversity in germline carriers and reveal an osteosarcoma-prone subgroup.

TP53 变异簇对种系携带者的表型多样性进行分层,并揭示出一个易患骨肉瘤的亚组。

Fischer Nicholas W, Ong Noel, Laverty Brianne, Psarianos Pamela, Giovino Camilla, Alon Noa, Montellier Emilie, Hainaut Pierre, Maxwell Kara N, Kratz Christian P, Kafri Ran, Malkin David

Clinical impact of TP53 functional mutations in patients with metastatic colorectal cancer treated with bevacizumab and chemotherapy

TP53功能突变对接受贝伐单抗和化疗治疗的转移性结直肠癌患者的临床影响

Ruzzo, Annamaria; Graziano, Francesco; Palladino, Silvia; Fischer, Nicholas W; Catalano, Vincenzo; Giordani, Paolo; Malkin, David; Tamburrano, Tiziana; Patriti, Alberto; Petrelli, Filippo; Sarti, Donatella; Chiari, Rita

Clustering of TP53 variants into functional classes correlates with cancer risk and identifies different phenotypes of Li-Fraumeni syndrome

TP53 变异体的功能分类与癌症风险相关,并可识别 Li-Fraumeni 综合征的不同表型。

Montellier, Emilie; Lemonnier, Nathanaël; Penkert, Judith; Freycon, Claire; Blanchet, Sandrine; Amadou, Amina; Chuffart, Florent; Fischer, Nicholas W; Achatz, Maria-Isabel; Levine, Arnold J; Goudie, Catherine; Malkin, David; Bougeard, Gaëlle; Kratz, Christian P; Hainaut, Pierre

Emerging insights into ethnic-specific TP53 germline variants

对种族特异性TP53种系变异的新认识

Fischer, Nicholas W; Ma, Yu-Heng Vivian; Gariépy, Jean

Association Between the Oligomeric Status of p53 and Clinical Outcomes in Li-Fraumeni Syndrome

p53寡聚状态与李-弗劳梅尼综合征临床结局的关联

Fischer, Nicholas W; Prodeus, Aaron; Tran, James; Malkin, David; Gariépy, Jean

Survival in males with glioma and gastric adenocarcinoma correlates with mutant p53 residual transcriptional activity

神经胶质瘤和胃腺癌男性患者的生存率与突变型p53残余转录活性相关。

Fischer, Nicholas W; Prodeus, Aaron; Gariépy, Jean

Serum-derived carcinoembryonic antigen (CEA) activates fibroblasts to induce a local re-modeling of the extracellular matrix that favors the engraftment of CEA-expressing tumor cells.

血清衍生的癌胚抗原 (CEA) 可激活成纤维细胞,诱导细胞外基质的局部重塑,从而有利于表达 CEA 的肿瘤细胞的植入

Abdul-Wahid Aws, Cydzik Marzena, Fischer Nicholas W, Prodeus Aaron, Shively John E, Martel Anne, Alminawi Samira, Ghorab Zeina, Berinstein Neil L, Gariépy Jean

VISTA.COMP - an engineered checkpoint receptor agonist that potently suppresses T cell-mediated immune responses

VISTA.COMP——一种经过基因工程改造的检查点受体激动剂,可有效抑制T细胞介导的免疫反应。

Prodeus, Aaron; Abdul-Wahid, Aws; Sparkes, Amanda; Fischer, Nicholas W; Cydzik, Marzena; Chiang, Nicholas; Alwash, Mays; Ferzoco, Alessandra; Vacaresse, Nathalie; Julius, Michael; Gorczysnki, Reginald M; Gariépy, Jean